Literature DB >> 28764217

Performance of Disease-Specific Scoring Models in Intensive Care Patients with Severe Liver Diseases.

Maged T El-Ghannam1, Moataz H Hassanien1, Mohamed D El-Talkawy2, Abdel Aziz A Saleem2, Amal I Sabry3, Hoda M Abu Taleb4.   

Abstract

INTRODUCTION: Egypt has the highest prevalence of Hepatitis C Virus (HCV) in the world, estimated nationally at 14.7%. HCV treatment consumes 20% ($80 million) of Egypt's annual health budget. Outcomes of cirrhotic patients admitted to the ICU may, in fact, largely depend on differences in the state of the disease, criteria and indications for admission, resource utilization, and intensity of treatment. AIM: The aim of the present study was to evaluate the efficacy of liver specific scoring models in predicting the outcome of critically ill cirrhotic patients in the ICU as it may help in prioritization of high risk patients and preservation of ICU resources.
MATERIALS AND METHODS: Over one year, a total of 777 patients with End Stage Liver Disease (ESLD) due to HCV infection were included in this retrospective non-randomized human study. All statistical analyses were performed by the statistical software SPSS version 22.0 (SPSS, Chicago, IL, USA). Child Turcotte Pugh (CTP) score, MELD score, MELD-Na, MESO, iMELD, Refit MELD and Refit MELD-Na were calculated on ICU admission.
RESULTS: ICU admission was mainly due to Gastrointestinal (GI) bleeding and Hepatic Encephalopathy (HE). Overall mortality was 27%. Age and sex showed no statistical difference between survivors and non survivors. Significantly higher mean values were observed for all models among individuals who died compared to survivors. MELD-Na was the most specific compared to the other scores. MELD-Na was highly predictive of mortality at an optimized cut-off value of 20.4 (AURC=0.789±0.03-CI 95%=0.711-0.865) while original MELD was highly predictive of mortality at an optimized cut-off value of 17.4 (AURC=0.678±0.01-CI 95%=0.613-0.682) denoting the importance of adding serum sodium to the original MELD. INR, serum creatinine, bilirubin, white blood cells count and hyponatremia were significantly higher in non survivors compared to survivors, while hypoalbuminemia showed no statistical difference. The advent of Hepatorenal Syndrome (HRS) and Spontaneous Bacterial Peritonitis (SBP) carried worse prognosis. Hyponatremia and number of transfused blood bags were additional independent predictors of mortality.
CONCLUSION: In cirrhosis of liver, due to HCV infection, patients who died during their ICU stay displayed significantly higher values on all prognostic scores at admission. The addition of sodium to MELD score greatly improves the predictive accuracy of mortality. MELD-Na showed the highest predictive value of all scores.

Entities:  

Keywords:  Cirrhosis; End stage liver disease; HCV infection; Liver specific scoring models; MELD-Na

Year:  2017        PMID: 28764217      PMCID: PMC5535409          DOI: 10.7860/JCDR/2017/24543.9980

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  34 in total

Review 1.  Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD.

Authors:  François Durand; Dominique Valla
Journal:  J Hepatol       Date:  2004-12-24       Impact factor: 25.083

2.  An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis.

Authors:  Angelo Luca; Berhard Angermayr; Guido Bertolini; Franz Koenig; Giovanni Vizzini; Martin Ploner; Markus Peck-Radosavljevic; Bruno Gridelli; Jaime Bosch
Journal:  Liver Transpl       Date:  2007-08       Impact factor: 5.799

3.  Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial.

Authors:  Alexander L Gerbes; Veit Gülberg; Pere Ginès; Guy Decaux; Peter Gross; Hassan Gandjini; Jacques Djian
Journal:  Gastroenterology       Date:  2003-04       Impact factor: 22.682

Review 4.  Surgery and portal hypertension.

Authors:  C G Child; J G Turcotte
Journal:  Major Probl Clin Surg       Date:  1964

5.  A prognostic model for predicting survival in cirrhosis with ascites.

Authors:  G Fernández-Esparrach; A Sánchez-Fueyo; P Ginès; J Uriz; L Quintó; P J Ventura; A Cárdenas; M Guevara; P Sort; W Jiménez; R Bataller; V Arroyo; J Rodés
Journal:  J Hepatol       Date:  2001-01       Impact factor: 25.083

6.  Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.

Authors:  Vasiliki Arvaniti; Gennaro D'Amico; Giuseppe Fede; Pinelopi Manousou; Emmanuel Tsochatzis; Maria Pleguezuelo; Andrew Kenneth Burroughs
Journal:  Gastroenterology       Date:  2010-06-14       Impact factor: 22.682

7.  Improved survival after variceal bleeding in patients with cirrhosis over the past two decades.

Authors:  Nicolas Carbonell; Arnaud Pauwels; Lawrence Serfaty; Olivier Fourdan; Victor George Lévy; Raoul Poupon
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

Review 8.  Inequities of the Model for End-Stage Liver Disease: an examination of current components and future additions.

Authors:  Kiran M Bambha; Scott W Biggins
Journal:  Curr Opin Organ Transplant       Date:  2008-06       Impact factor: 2.640

9.  The model for the end-stage liver disease and Child-Pugh score in predicting prognosis in patients with liver cirrhosis and esophageal variceal bleeding.

Authors:  Daniela Benedeto-Stojanov; Aleksandar Nagorni; Goran Bjelaković; Dragan Stojanov; Bojan Mladenović; Nebojsa Djenić
Journal:  Vojnosanit Pregl       Date:  2009-09       Impact factor: 0.168

Review 10.  The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis.

Authors:  Yousra A Mohamoud; Ghina R Mumtaz; Suzanne Riome; Dewolfe Miller; Laith J Abu-Raddad
Journal:  BMC Infect Dis       Date:  2013-06-24       Impact factor: 3.090

View more
  3 in total

1.  Value of the albumin-bilirubin score in the evaluation of hepatitis B virus-related acute-on-chronic liver failure, liver cirrhosis, and hepatocellular carcinoma.

Authors:  Qing Lei; Yinhua Zhang; Changzheng Ke; Chunchun Yan; Ping Huang; Haixia Shen; Huiting Lei; Yue Chen; Jie Luo; Zhongji Meng
Journal:  Exp Ther Med       Date:  2018-01-12       Impact factor: 2.447

2.  Establishment of prognostic scoring models for different etiologies of acute decompensation in hospitalized patients with cirrhosis.

Authors:  Qun Cai; Mingyan Zhu; Jinnan Duan; Hao Wang; Jifang Sheng
Journal:  J Int Med Res       Date:  2019-07-31       Impact factor: 1.671

3.  The predictive value of MELDNa (model for end-stage liver disease-sodium) and mean platelet volume/platelet count for patients' 30-day mortality after liver transplantation.

Authors:  Vecihe Bayrak; Mehmet Çağatay Gürkök; Ferhan Demirer Aydemir; Bişar Ergün; Tufan Egeli; Nurcan Şentürk Durukan; Tarkan Ünek; Necati Gökmen
Journal:  Clin Exp Hepatol       Date:  2022-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.